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Genetics play a pivotal role in cancer. This is best exemplified in
sporadic intestinal cancer development, which usually starts with
mutations in APC then in Ras, p53 and TGFβ (Sears and Garrett,
2014). Nevertheless, intestinal bacteria, diet and lifestyle con-
tribute significantly to mucosal inflammation and cancer (Anand
et al., 2008; Kostic et al., 2014; Sears and Garrett, 2014). An
effective approach to study the aforementioned factors may be
to analyze them combinatorially. In this regard, intestinal dys-
biosis is a useful concept to describe harmful changes in the
constitution of the microbiota. Another imbalance occurs during
inflammatory bowel disease due to an excessive immune response
to the intestinal microbiota, which in turn may lead to dys-
biosis and perpetuate inflammation. Suspected factors, such as
immune system mutations or tissue-damaging microbial strains,
may not suffice to promote inflammation and cancer in the
absence of co-founding factors that create or sustain an imbal-
ance. Thus, a broad unifying concept may describe disease as dys-
functional interactions among environmental factors, such as diet
and lifestyle, microbiota composition, and the genetic of the host.
Moreover, aging affects the onset of inflammation and cancer,
the host microbiota and the occurrence of sporadic mutations.
Accordingly, the host genetic background and that of the micro-
biome, define the intestinal hologenome, which is influenced by
age and the environment toward homeostasis or disease. Thus,
intestinal disease may ensue when the intestinal hologenome
is imbalanced, that is, when a genetically predisposed or old
host interacts with its dysbiotic microbiota in an inadequate or
harmful dietary or lifestyle-shaped environment.
The review and opinion articles accompanying this editorial
describe key aspects of modeling the hologenome with an empha-
sis on intestinal infection, inflammation and cancer. One major
issue discussed is the adaptation of Koch’s postulates in order
to assess causation between the human opportunistic pathogen
Pseudomonas aeruginosa and intestinal disease in patients with
cancer (Markou and Apidianakis, 2014).While Enterobacteriaceae
are suspected contributors to intestinal inflammation and can-
cer, P. aeruginosa exemplifies the opportunistic nature of many
bacterial species toward colonization and disease. The suggested
guidelines therefore provide a simple framework within which
clinical associations, experimental data, and improved outcomes
upon treatment against suspected bacteria need to be taken into
account in order to prove causation.
Experimental data can be obtained with the various mouse
models of intestinal inflammation and cancer described compre-
hensively by Gkouskou et al. (2014). This review article describes
the contributing role of microbiota as a whole, as well as that of
specific bacterial species in exacerbating the disease. Interestingly,
Enterobacteriaceae and Bacteroides species contribute to disease
progression in various mouse models. In addition, intestinal dys-
biosis is influenced by diet, antibiotics, and an immune genetic
background conducive to exacerbated adaptive and diminished
innate immune response. The authors highlight the potential
of targeting the dysbiosis-inflammation-tumorigenesis axis for
the development of novel therapeutic strategies for IBD and
colorectal cancer.
Whereas studies on bacteria dominate the literature on the
role of dysbiosis in inflammation and cancer, viruses were his-
torically the first microbes to be linked to cancer. A modern
approach to this issue is described by Iacovides and colleagues
who suggest that the interplay between cancer and cell stemness
can be influenced by oncogenic viruses (Iacovides et al., 2013).
These viruses interfere with signaling pathways that are tradition-
ally associated with self-renewal and lineage-commitment. Thus
virus-associated cancers can serve as models to understand the
link between viral infection, cancer, and stemness.
Innate immune and stress responses lie at the intersection of
apoptosis and cell proliferation during inflammation and can-
cer. In this regard the simple model organism Caenorhabditis
elegans has provided valuable insights into the tight regulation
of apoptosis during development, infection, and DNA damage
(Arvanitis et al., 2013). These findings have been taken a few steps
further with the use ofDrosophilamodels of infection and cancer,
as reviewed by Bangi (2013). This review illustrates the key role
of stress, innate immunity, and inflammatory signaling pathways
in promoting intestinal stem cell proliferation and tumorigen-
esis. Prominent among these pathways is the c-Jun-N-terminal
kinase (JNK) cascade, which in an oncogenic background can
be diverted from tissue damage- or infection-mediated apopto-
sis to tumor cell proliferation and invasion (Apidianakis et al.,
2009; Cordero et al., 2010; Bangi et al., 2012). Ligoxygakis and col-
leagues contribute a thorough review on Drosophila hemocytes,
describing the multifaceted roles of these innate immunity cells
in development, immunosurveillance, and tumorigenesis (Wang
et al., 2014). Kim and Lee explain the multiple roles of Drosophila
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Duox, an NADPH oxidase, the homologs of which mediate bac-
terial killing via oxygen radicals in mammalian mucosae and
phagocytes (Kim and Lee, 2014). The authors provide insights
into the role of Duox in gut immunity, homeostasis of the intesti-
nal epithelium, and stem cell proliferation. Complementarily,
Ayyaz and Jasper put in perspective aging and three responses
of Drosophila to intestinal microbes, namely, Duox, the Immune
deficiency NF-κB pathway, and the renewal of intestinal ente-
rocytes (Ayyaz and Jasper, 2013). These two reviews provide a
comprehensive analysis of intestinal dysbiosis and accompanying
intestinal cell renewal, which is a homeostatic arm of the intestinal
host defense induced either by pathogenic or seemingly innocu-
ous bacteria, and showcase the usefulness ofDrosophila as amodel
for the study of intestinal immunity, inflammation, and disease.
Regenerative and tumor-promoting cytokines in Drosophila
and mammals may not necessarily emanate from tissue infil-
trating blood cells (Panayidou and Apidianakis, 2013; Gkouskou
et al., 2014). The review by Kux and Pitsouli highlights that
regeneration signals are not confined to the Drosophila intestinal
epithelium (Kux and Pitsouli, 2014). Neighboring tissues, such
as muscles, trachea and potentially the neural system communi-
cate with intestinal epithelial cells, and thus might contribute to
the intestinal stem cell niche. Accordingly, regenerative or tumor-
promoting inflammatory signaling may be controlled not only by
tumors and their microenvironment, but also by remote organs.
Taking a far-reaching perspective, Droujinine and Perrimon pro-
vide an educated guess on the tissues that may systemically pro-
vide inflammatory and other inter-organ signals either locally or
systemically (Droujinine and Perrimon, 2013). The authors fore-
see the existence of a vast inter-organ communication network
(ICN) of peptides, proteins, and metabolites that act in-between
organs to coordinate cellular processes, either under homeostatic
or stress conditions. A unique strength of the Drosophilamodel is
that biochemical studies can be combined to in vivo genome-wide
organ-specific genetic screens to identify ICN components.
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